BACKGROUND: Vitamin D deficiency is associated with increased disease activity in multiple sclerosis (MS), but its role in progressive MS has not been elucidated. The objective was to determine the correlation between vitamin D levels and visual parameters in primary progressive MS (PPMS) and secondary progressive MS (SPMS). METHODS: Serum 25-hydroxyvitamin D (25[OH]D) and 25-hydroxyvitamin D3 (25[OH]D3) levels were obtained from the Secondary and Primary Progressive Ibudilast NeuroNEXT Trial in MS (SPRINT-MS). Visual function measurements and vitamin D associations were determined using the Pearson correlation and the generalized linear mixed model. RESULTS: The analysis included 258 patients (mean ± SD age of 55.6 ± 7.3 years, 52.7% female, and 52.3% PPMS). Mean vitamin D values were above sufficiency and were similar between PPMS and SPMS (P = .47 and P = .31). There was no association between 25(OH)D3 levels and any visual markers, including peripapillary retinal nerve fiber layer thickness (Spearman r = -0.08), macular volume (r = -0.03), ganglion cell-inner plexiform layer (r = -0.07), and 2.5% low-contrast visual acuity test (r = -0.10). No statistically significant associations between vitamin D levels and visual system measurements were detected in the PPMS and SPMS subgroups. CONCLUSIONS: Vitamin D levels were not associated with optical coherence tomography findings or low-contrast letter acuity in this group of patients with progressive MS.
BACKGROUND: Vitamin D deficiency is associated with increased disease activity in multiple sclerosis (MS), but its role in progressive MS has not been elucidated. The objective was to determine the correlation between vitamin D levels and visual parameters in primary progressive MS (PPMS) and secondary progressive MS (SPMS). METHODS: Serum 25-hydroxyvitamin D (25[OH]D) and 25-hydroxyvitamin D3 (25[OH]D3) levels were obtained from the Secondary and Primary Progressive Ibudilast NeuroNEXT Trial in MS (SPRINT-MS). Visual function measurements and vitamin D associations were determined using the Pearson correlation and the generalized linear mixed model. RESULTS: The analysis included 258 patients (mean ± SD age of 55.6 ± 7.3 years, 52.7% female, and 52.3% PPMS). Mean vitamin D values were above sufficiency and were similar between PPMS and SPMS (P = .47 and P = .31). There was no association between 25(OH)D3 levels and any visual markers, including peripapillary retinal nerve fiber layer thickness (Spearman r = -0.08), macular volume (r = -0.03), ganglion cell-inner plexiform layer (r = -0.07), and 2.5% low-contrast visual acuity test (r = -0.10). No statistically significant associations between vitamin D levels and visual system measurements were detected in the PPMS and SPMS subgroups. CONCLUSIONS: Vitamin D levels were not associated with optical coherence tomography findings or low-contrast letter acuity in this group of patients with progressive MS.
Authors: Stephanie B Syc; Shiv Saidha; Scott D Newsome; John N Ratchford; Michael Levy; E'tona Ford; Ciprian M Crainiceanu; Mary K Durbin; Jonathan D Oakley; Scott A Meyer; Elliot M Frohman; Peter A Calabresi Journal: Brain Date: 2011-10-17 Impact factor: 13.501
Authors: Muhammad Taimur Malik; Brian C Healy; Leslie A Benson; Pia Kivisakk; Alexander Musallam; Howard L Weiner; Tanuja Chitnis Journal: Neurology Date: 2014-05-21 Impact factor: 9.910
Authors: Bess Dawson-Hughes; Robert P Heaney; Michael F Holick; Paul Lips; Pierre J Meunier; Reinhold Vieth Journal: Osteoporos Int Date: 2005-03-18 Impact factor: 4.507
Authors: Steve Simpson; Bruce Taylor; Leigh Blizzard; Anne-Louise Ponsonby; Fotini Pittas; Helen Tremlett; Terence Dwyer; Peter Gies; Ingrid van der Mei Journal: Ann Neurol Date: 2010-08 Impact factor: 10.422
Authors: Kathryn C Fitzgerald; Kassandra L Munger; Karl Köchert; Barry G W Arnason; Giancarlo Comi; Stuart Cook; Douglas S Goodin; Massimo Filippi; Hans-Peter Hartung; Douglas R Jeffery; Paul O'Connor; Gustavo Suarez; Rupert Sandbrink; Ludwig Kappos; Christoph Pohl; Alberto Ascherio Journal: JAMA Neurol Date: 2015-12 Impact factor: 18.302
Authors: I A F van der Mei; A-L Ponsonby; T Dwyer; L Blizzard; B V Taylor; T Kilpatrick; H Butzkueven; A J McMichael Journal: J Neurol Date: 2007-04-11 Impact factor: 4.849
Authors: E Gordon-Lipkin; B Chodkowski; D S Reich; S A Smith; M Pulicken; L J Balcer; E M Frohman; G Cutter; P A Calabresi Journal: Neurology Date: 2007-10-16 Impact factor: 9.910
Authors: Anne-Hilde Muris; Joost Smolders; Linda Rolf; Lieke J J Klinkenberg; Noreen van der Linden; Steven Meex; Jan Damoiseaux; Raymond Hupperts Journal: PLoS One Date: 2016-06-08 Impact factor: 3.240
Authors: Raymond Hupperts; Joost Smolders; Reinhold Vieth; Trygve Holmøy; Kurt Marhardt; Myriam Schluep; Joep Killestein; Frederik Barkhof; Manolo Beelke; Luigi M E Grimaldi Journal: Neurology Date: 2019-10-08 Impact factor: 9.910